QualityStocksNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) to Present at VirtualInvestorConferences.com
Willow Biosciences (TSX: WLLW) (OTCQB: CANSF), based in Vancouver, Canada, focused on manufacturing pharmaceutical grade quality cannabinoids via synthetic biology, today announced that its CEO and President Trevor Peters will present live at VirtualInvestorConferences.com at 12:00 p.m. Eastern Time on Thursday, July 9. Interested parties are encouraged to visit www.VirtualInvestorConferences.com to pre-register and run the online system check to expedite participation and receive event updates. An archived webcast will be made available after the event for those unable to join live on the day of the conference.
To view the full press release, visit http://ibn.fm/n25lQ
About Willow Biosciences Inc.
Willow is a Canadian biotechnology company based in Vancouver, Canada, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.
NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW